Zuzana Krátká, Jaroslav Janošek, Tomáš Fürst
On June 15, 2022, the FDA panel of experts approved Pfizer’s Comirnaty vaccine for emergency use in children aged 6 months to <5 years. It did so despite the evidence of the ineffectiveness of … Číst dále “Report on the FDA’s Failure Regarding Approval of the Comirnaty mRNA Vaccine for Children Aged 6 Months to
Článek Report on the FDA’s Failure Regarding Approval of the Comirnaty mRNA Vaccine for Children Aged 6 Months to <5 Years se nejdříve objevil na Sdružení mikrobiologů, imunologů a statistiků | SMIS .
